Alpa Laboratories Ltd

Alpa Laboratories Ltd | Sector: Pharmaceuticals | ISIN: INE385I01010

₹ 54.10 (-3.13%) icon

24 Mar, 2023, 2:52:48 PM
Open
₹ 57.00
Prev. Close
₹ 55.85
Turnover(lac)
₹ 15.34
Day's High
₹ 57.00
Day's Low
₹ 53.70
52 Wk High
₹ 89.70
52 Wk Low
₹ 47.35
Book Value
₹ 66.37
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 113.83
P/E
27.00
EPS
2.06
Div. Yield
0.00

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 3/24/2023 2:52:48 PM

    ₹ 54.1 -1.75 -3.13
  • Open
  • ₹ 57
  • Prev. Close
  • ₹ 55.85
  • Turnover(Lac.)
  • ₹ 15
  • Day's High
  • ₹ 57
  • Day's Low
  • ₹ 53.7
  • 52 Week's High
  • ₹ 89.7
  • 52 Week's Low
  • ₹ 47.35
  • Book Value
  • ₹ 66.37
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 113.83
  • P/E
  • 27
  • EPS
  • 2.06
  • Divi. Yield
  • 0

Corporate Actions

03 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Feb , 2023

12:00 AM

02 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Nov , 2022

12:00 AM

14 Sep , 2022

12:00 AM

AGM

Announcement date: 14 Sep , 2022

View Details

02 Aug , 2022

12:00 AM

02 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

14 Sep , 2022

12:00 AM

BookCloser

View Details

SHAREHOLDING SNAPSHOT
24 March , 2023 | 02:53 PM

PROMOTER - TOTAL57.29%

Indian: 57.29%

Foreign: 0%

NON-PROMOTER - TOTAL 42.71%

Institutions: 0.00%

Non-Institutions: 42.71%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Alpa Laboratories Ltd News and Update

Image not found
  • 8 hours ago |
  • 4:03 PM

According to a BSE filing, the parties to the proposed transaction, for which a legally binding memorandum of understanding had previously been signed, had "executed a Share Purchase Agreement and finalized the transaction."

Article Image
  • IIFL News Service |
  • 1 day ago |
  • 4:02 PM
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Alpa Laboratories Ltd

  • Mahendra Singh Chawla

  • Chairman & Exec. Director
  • Pravin C Shah

  • Executive Director
  • Sharad Chand Lunawat

  • Independent Director
  • Devendra Baheti

  • Independent Director
  • Krishna Das Malani

  • Independent Director
  • Paresh Chawla

  • Managing Director
  • Jyoti Jain

  • Independent Director
  • Swati Bagh

  • Company Sec. & Compli. Officer
  • Vitthal Kothana

  • Executive Director

Summary

Mr. Purushottam R. Patel, Mr. M.S. Chawla and Mr. Pravin C. Shah, partners of M/s Alpa Laboratories, which was formed in the year 1967, incorporated a private limited company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In the year 1998, Alpa Laboratories Private Limited was converted into a public limited company with effect from September 3, 1998 with the name of Alpa Laboratories Limited.In the year 1997, the company has initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. The company has manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark Alpa which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. The company has also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc.... Read More


Reports by Alpa Laboratories Ltd


Reports by Alpa Laboratories Ltd